1. Home
  2. CVCO vs XENE Comparison

CVCO vs XENE Comparison

Compare CVCO & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVCO
  • XENE
  • Stock Information
  • Founded
  • CVCO 1965
  • XENE 1996
  • Country
  • CVCO United States
  • XENE Canada
  • Employees
  • CVCO N/A
  • XENE N/A
  • Industry
  • CVCO Homebuilding
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVCO Consumer Discretionary
  • XENE Health Care
  • Exchange
  • CVCO Nasdaq
  • XENE Nasdaq
  • Market Cap
  • CVCO 3.8B
  • XENE 3.3B
  • IPO Year
  • CVCO N/A
  • XENE 2014
  • Fundamental
  • Price
  • CVCO $515.86
  • XENE $39.98
  • Analyst Decision
  • CVCO Buy
  • XENE Strong Buy
  • Analyst Count
  • CVCO 2
  • XENE 7
  • Target Price
  • CVCO $487.50
  • XENE $56.00
  • AVG Volume (30 Days)
  • CVCO 59.3K
  • XENE 405.9K
  • Earning Date
  • CVCO 01-30-2025
  • XENE 02-27-2025
  • Dividend Yield
  • CVCO N/A
  • XENE N/A
  • EPS Growth
  • CVCO 2.67
  • XENE N/A
  • EPS
  • CVCO 20.25
  • XENE N/A
  • Revenue
  • CVCO $1,927,218,000.00
  • XENE N/A
  • Revenue This Year
  • CVCO $10.88
  • XENE N/A
  • Revenue Next Year
  • CVCO $7.24
  • XENE $1,600.08
  • P/E Ratio
  • CVCO $25.65
  • XENE N/A
  • Revenue Growth
  • CVCO 4.11
  • XENE N/A
  • 52 Week Low
  • CVCO $331.08
  • XENE $35.53
  • 52 Week High
  • CVCO $544.08
  • XENE $50.99
  • Technical
  • Relative Strength Index (RSI)
  • CVCO 70.15
  • XENE 50.76
  • Support Level
  • CVCO $465.19
  • XENE $39.25
  • Resistance Level
  • CVCO $526.50
  • XENE $41.40
  • Average True Range (ATR)
  • CVCO 14.08
  • XENE 1.30
  • MACD
  • CVCO 6.25
  • XENE 0.10
  • Stochastic Oscillator
  • CVCO 83.22
  • XENE 56.71

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Share on Social Networks: